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Background: Prepubertal hypertrichosis is a reportedly benign condition characterized by an excessive growth of
vellous hair in non-androgen dependent areas of the body compared to the amount usually present in normal
subjects of the same age, race and sex. Although this condition is usually considered idiopathic and regarded as
benign, it may be very disturbing cosmetically, causing significant patient and parental anxiety.
Method: We performed a hormonal and androgen receptor study in 42 prepubertal girls with hypertrichosis
and 29 control girls from 2 to 8 years of age. Both groups underwent a determination of basal LH, FSH,
17OH progesterone, androstenedione, testosterone, estradiol and SHBG, abdominal ultrasound to assess ovarian
morphology, and the number of androgen receptor CAG/GGC repeats in DNA obtained from peripheral leukocytes.
Results: The hypertrichosis score was higher in the cases compared to controls. Serum gonadotropins and sex
steroids were similar in both groups, but SHBG was significantly lower in the girls with hypertrichosis (71.1 ± 2.9
vs 81.9 ± 3.0 nmol/L, p < 0.02). The distribution of shorter, larger and total alleles was not statistically different
between cases and controls. The combined analysis of CAG/GGC, however, showed a significantly higher
prevalence of the most androgen-sensitive haplotypes (1–2: <22CAG + 17/17GGC- < 14CAG + 17/18GGC) in girls
with hypertrichosis compared to controls.
Conclusions: We conclude that girls with hypertrychosis exhibit AR(s) with enhanced sensitivity, which may
facilitate the growth of their body hair.
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Prepubertal hypertrichosis is a reportedly benign condi-
tion characterized by an excessive growth of vellous hair
in non-androgen dependent areas of the body compared
to the amount usually present in normal subjects of the
same age, race and sex [1]. Characteristically, the hair in
subjects with hypertrichosis usually grows on the trunk,
arms and legs. This form of hypertrichosis was described
by Barth et al. in 1988 [2], and differs from universal
congenital hypertrichosis [3,4] and hypertrichosis lagugi-
nosa [5]. Although this condition is usually considered
idiopathic and regarded as benign, it may be very dis-
turbing cosmetically, causing significant patient and* Correspondence: mihernandezc@gmail.com
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article, unless otherwise stated.parental anxiety. In addition, hypertrichosis may be asso-
ciated with metabolic or genetic disorders, and with the
use of drugs [6-11].
Studies concerning the hormonal profile of subjects
with hypertrichosis are relatively few and difficult to
compare, due to the various definitions of this condition.
In addition, the investigation of androgen metabolism
has not shown significant differences between girls with
hypertrichosis and controls [12,13].
The human androgen receptor (AR) is the main regulator
of androgen signaling in the cell [14] and is encoded by the
AR gene encoded in the X-chromosome [15]. The transac-
tivator domain of the AR protein contains two polymorphic
trinucleotide repeats segments that encode poly -glutamine
(CAG)n and –glycine (GGN)n tracts within exon 1. There
are considerable data linking the length of CAG repeats to
androgen sensitivity in vivo as well as in vitro, that suggeststral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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gen receptor sensitivity [16]. In the case of GGC, AR with
repeats number other than 17 GGC(23GGN), exhibit lower
transactivation in response to androgens, suggesting a rela-
tionship between repeat lengths and AR function [16].
The aim of our study was to evaluate the clinical and
hormonal characteristics of a large group of girls with
hypertrichosis, and to assess the number of CAG and
GGC repeats in their androgen receptor gene.
Subjects and methods
Subjects
A group of 42 prepubertal girls with hypertrichosis was re-
cruited from our endocrine clinic, and matched by age
with a group of 29 prepubertal control girls without
hypertrichosis. The age of both groups of girls ranged be-
tween 2 to 8 years. Exclusion criteria were: 1) Any clinical
sign of puberty according to Marshall and Tanner stages,
ultrasonography or hormonal profile. 2) Chronic disease
(including congenital adrenal hyperplasia) 3) Medication
that could induce hypertrichosis or hyperandrogenism.
4) Low birth weight and 5) Maternal history of polycys-
tic ovary syndrome.
Study protocol
After an overnight fast, all girls were evaluated at the Insti-
tute of Maternal and Child Research of the University of
Chile. The patients and control girls underwent a careful
physical examination performed by a single pediatric
endocrinologist (MIH), to determine their hypertrichosis
score according to Gryngarten et al. [13]. As indicated by
this author, a score above 7 was considered positive for
hypertrichosis.
Height was measured using a Harpenden stadi-
ometer (Holtain, UK). Weight was measured using a
manual scale with a 10-g gradation (Seca; Quickmedical,
Snoqualme,WA). All the measurements were expressed as
SDS for chronological age.
We obtained a hand x-ray to determine the bone age
according to the method of Greulich and Pyle [17]. This
determination was performed by a single observer (AE),
who was blinded to the condition of the girls. A transab-
dominal ultrasound was performed by a single ultraso-
nographist (AE) with a 5-MHz transducer in Sonoace
6000C equipment (Madison Co., Seoul, Korea). Ovarian
volume was calculated using the simplified formula for a
prolate ellipsoid [18] and we determined the number of
follicles in each ovary.
Basal levels of androstenedione, FSH, LH, estradiol, tes-
tosterone, 17 hydroxyprogesterone (17OH Prog), SHBG,
antimullerian hormone (AMH) and inhibin-B were ob-
tained and measured in a fasting sample at 8:00 AM.
SHBG and testosterone were used to calculate the free an-
drogen index (FAI), as previously reported [19].Hormone assays
Serum testosterone, androstenedione, 17OH Prog, DHEA-
S and estradiol were determined by competitive specific
binding RIA, and serum LH, FSH, and SHBG were mea-
sured by immunoradiometric assays. All kits were supplied
by Diagnostic System Laboratories (Webster, TX). Intra-
assay coefficients of variation were 5.1% for testosterone,
3.2% for androstenedione, 4.2% for 17-OH Prog, 3.5% for
DHEA-S, 4,1% for estradiol, 6.5% for LH, 3.6% for FSH,
and 3.9% for SHBG. Interassay coefficients of variation
were 6.4% for testosterone, 6.1% for androstenedione, 5.5%
for 17-OH Prog, 5.1% for DHEA-S, 6.7% for estradiol, 7.6%
for LH, 6.2% for FSH, and 6.9% for SHBG. Serum AMH
was assayed using the AMH/MIS ELISA kit (Immunotech-
Beckman, Marseilles, France). The AMH assay had a sensi-
tivity of 0.7 pmol/L, and intra- and interassay coefficients
of variation of 5.3% and 8.7% respectively. Serum inhibin B
was measured using specific two-site ELISAs (Diagnostic
Systems Labs, Webster TX). The assay sensitivity was
7 pg/mL, and intra- and inter-assay coefficients of variation
were 4.8% and 7.1% respectively.Determination of CAG and GGC repeats
Genomic DNA was extracted from peripheral blood
lymphocytes using a DNA blood Wizard kit. The AR
exon 1 region encoding the polyglutamine repeat was
amplified using PCR. To determine the length of the
CAG and GGC repeats, we amplified the corresponding
regions located on exon 1 of the AR gene (Genebank ac-
cession nº AL049564) using a pair of primers whose se-
quence has been previously reported [20,21]. One
primer from each pair was marked with fluorescent dye
(FAM or NED). Amplification was performed in a 15 μL
reaction volume, containing 150 ng of DNA, 200 M of
each deoxynucleotide triphosphate (Invitrogen, USA),
1X Mg2+-free DyNAzime EXT Buffer (FINNZYMES OY,
Finland), 8% DMSO (FINNZYMES OY, Finland), 2.5 mM
MgCl2 (FINNZYMES OY, Finland), 1 μM of GGC or
CAG primers and 0.6 U of DyNAzime EXT DNA poly-
merase (FINNZYMES OY, Finland). PCR conditions for
CAG were: 35 cycles of 95°C for 45 sec, 60°C for 45 sec,
and 72°C for 1 min. PCR conditions for CGC were: 30 cy-
cles of 95°C for 1 min, 55°C for 2 min, and 72°C for 2 min.
PCR for CAG and GGC were initiated with a denaturation
step of 95°C for 5 min, and terminated with an extension
step at 72°C for 10 or 5 min, respectively.
PCR fragments separation of PCR product were per-
formed by automated capillary electrophoresis, using an
ABI PRISM 310 Genetic Analyzer (Applied Biosystems),
and the length was determined with Genemapper Analysis
Software (version V.3.2) (Applied Biosystems). 2 μL of the
PCR product was mixed with 10 μL of formamide and
0.3 μL of GeneScan ROX-500 Size Standard (Applied
Table 1 Baseline characteristics of cases and controls
Cases Controls
Age (yrs) 6 ± 2 6 ± 2
Bone Age (yrs) 5.5 ± 0.3 6.7 ± 0.4
Hypertrichosis score 16 ± 4 3 ± 2**
BMI (k/m2) SDS 1 ± 0.1 0.9 ± 0.3
Follicle number per ovary 4.8 ± 2.4 3.7 ± 1.3
mean ± SD; Kruskall-Wallis test **P < 0.01 cases vs controls.
Table 2 Hormonal profile of cases and controls
Cases Controls
Testosterone (ng/mL) 0.14 ± 0.06 0.14 ± 0.06
Androstenedione (ng/mL) 0.3 ± 0.4 0.2 ± 0.2
DHEAS (ng/mL) 116 ± 162 96 ± 84
SHBG (nmol/L) 71 ± 16 82 ± 15*
Free androgen index 0.83 ± 0.67 0.62 ± 0.36
Estradiol (pg/mL) 7.85 ± 5.0 8.2 ± 4.5
Inhibin (pg/mL) 16 ± 14 11 ± 4
AMH(pM) 23.4 ± 2.0 29.6 ± 4.2
Insulin (uUI/ml) 5.9 ± 0.6 5.6 ± 0.1
mean ± SD; Kruskall-Wallis test *P < 0.05 cases vs controls.
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cooled on ice.
The fragments size were compared in each capillary
electrophoresis with PCR products obtained from men
whose repeat lengths were known (standard automated
sequencing, Macrogen Inc, Korea) in a single and pooled
forms for CAG (13, 14, 17, 18, 19, 21, 22, 23, 24, 25, 28)
and GGC (9, 13, 14, 17, 18). Standard automated sequen-
cing was performed using two different amplicons that
contained CAG or GGC repeats. The CAG and GGC
amplicons were obtained after PCR reactions with CAG
(A0 and A5) and GGC pair of primers (A3n and A10) as
previously described [22]. Amplification was performed in
a 25 L reaction volume, containing 150 ng of DNA,
200 M of each deoxynucleotide triphosphate (Invitrogen,
USA), 1X Optimized DyNAzime EXT Buffer (FINN-
ZYMES OY, Finland), 8% DMSO (FINNZYMES OY,
Finland), 0.3 μM of each one sense or antisense primer
and 1 U of DyNAzime EXT DNA polymerase (FINN-
ZYMES OY, Finland). Both PCR reactions were per-
formed under the same conditions: 37 cycles of 94°C
for 1 min, 58°C for 1 min and 72°C for 1 min; initiated
with a denaturation step of 94°C for 3 min, and termi-
nated with an extension step at 72°C for 10 min.
The protocol was approved by the Institutional Review
Boards of the Hospital San Borja Arriaran and the Fac-
ulty of Medicine, University of Chile. All parents signed
an informed consent at the beginning of the study.
Statistical analysis
Results are expressed as mean ± SD. Statistical analysis
was performed using SPSS 10.0 for Windows (SPSS Inc.,
Chicago, IL). Normality of variables was assessed using
the Kolmogorov-Smirnov test. Differences between girls
with hypertrichosis and control girls were assessed by the
Kruskall-Wallis or the Mann–Whitney test for non-
parametric variables. To compare the number of CAG
and GGC repeats in short, large and total alleles between
girls with hipertrichosis and control girls we used the chi-
square test. P < 0.05 was considered statistically significant.
Results
Hypertrichosis score and general assessment
The mean hypertrichosis score in the control group was
3 ± 2 and, as expected, none of these girls expressed con-
cern about their body hair. The mean score observed in
the girls with hypertrichosis was 16 ± 7, which was signifi-
cantly higher compared to the control group (Table 1).
The girls with hypertrichosis had long and dense vellous
hair covering mainly the trunk, sacrum, upper and lower
limbs, exceeding what is commonly observed in our popu-
lation of prepubertal girls.
The mean chronological and bone age was similar in
the girls with hypertrichosis and the control group, asshown in Table 1. Their weight and BMI were also com-
parable (Table 1).
Ultrasound study
We did not find any differences in uterine or ovarian
size between both groups of girls. The number of folli-
cles per ovary, however, was higher in girls with hyper-
trichosis compared with controls (4.8 ± 0.5 vs 3.7 ± 0.3,
p < 0.05) (Table 1).
Hormone assays
Basal serum levels of LH, FSH and estradiol levels were
similar in both groups of girls, and in the range usually
observed in prepubertal girls. Basal DHEA-S, 17OH pro-
gesterone, androstenedione, inhibin-B and AMH were
similar in both groups, and 17 OH progesterone and
androstenedione. Interestingly, girls with hypertrichosis
had significantly lower levels of SHBG than control girls
(71.16 ± 16 vs 82 ± 15, p < 0.05). We did not observe sta-
tistically significant differences in the free androgen
index between both groups of girls (0.83 ± 0.67 vs 0.62 ±
0.36 in hypertrichosis vs controls, p = NS) (Table 2).
CAG repeats analysis
The mean number of CAG repeats was 17.5 ± 3.1 vs
17.4 ± 3.0 in girls with hypertrichosis and control girls
respectively, which was within the normal range ob-
served in the general population [23,24]. Allele distribu-
tion for CAG repeats length was homozygous in 5 and
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gous in 95% and 93% of cases and control girls respect-
ively, not showing any differences between cases and
controls.GGC repeat analysis
The mean number of GGC repeats was not statistically
significantly different between both groups (17.4 ± 1.1 vs
17.4 ± 0.61 in cases and controls respectively), and
remained within the normal range for the general popu-
lation [23,24]. Examination of the allele distribution did
not reveal any difference in alleles with 17 or less repeats
in the girls with hypertrichosis compared with controls.
The GGC repeats length was homozygous in 70% and
69% of cases and controls, respectively, and heterozy-
gous in 30% and 31% of cases and controls, respectively.
The combined analysis of CAG/GGC, however, showed
a significantly higher prevalence of the most androgen-
sensitive haplotypes (1–2: <22CAG+ 17/17GGC - <14C
AG+ 17/18GGC) in the girls with hypertrichosis com-
pared with controls (36% vs 14%, p < 0.05). Distribution of
combination CAG/GGC haplotypes is shown in Table 3.
In girls with the most androgen-sensitive haplotypes tes-
tosterone, DHEAS and androstenedione levels were sig-
nificantly lower than in the girls with less sensitive
haplotypes (p < 0.03).
The hormonal levels according to CAG/GGC haplo-
types are shown in Table 4. We observed that girls with
hypertrichosis who harbor haplotypes 3–5 have lower
SHBG concentrations compared to controls with the
same haplotype.
In contrast, we observed that cases with the haplo-
types 1–2 have normal androgen levels.Discussion
Prepubertal hypertrichosis is a poorly understood clinical
entity which may cause significant patient and parental
anxiety. In this study, we performed an assessment of
ovarian function and androgen receptor repeat polymor-
phisms in a large group of carefully selected prepubertalTable 3 Distribution of combination CAG/GGC haplotypes
Hap N° CAG/GGC haplotypes definition
1 <22CAG + 17/17GGC
2 <14CAG + 17/18GGC
3 (≥18 and < 22)CAG + 17/18GGC
4 <22CAG + (<17 and/or >17)GGC
5 ≥22/22CAG + (17 and/or 18)GGC
Total (n)
One girl with hypertrichosis had a genotype: 20/27 CAG and 14/17 GGC and theref
The prevalence of the most sensitive combinations (1 and 2) was significantly higher ingirls with this condition, which were compared with a
group of control girls.
The limited data available regarding the androgen
profile of girls with prepubertal hypertrichosis are
somewhat controversial. Balducci and Toscano demon-
strated elevated concentrations of serum dihydrotestos-
terone (DHT) in a small group of prepubertal girls with
hypertrichosis compared with age-matched controls.
These authors, however, did not observe a concomitant
increase in the levels of the DHT metabolite 3α-
androstanediol glucuronide [12]. Gryngarten et al. ob-
served increased serum testosterone levels and FAI in a
group of prepubertal girls with hypertricosis compared to
controls. In addition, they observed a slight increase in
3α-androstanediol glucuronide concentrations in approxi-
mately half of their girls with hypertrichosis [13].
We evaluated 42 prepubertal girls with hypertrichosis
that were matched with 29 control prepubertal girls. We
did not observe any differences in the androgen profile
of both groups, except for lower levels of SHBG in the
girls with hypertrichosis, although FAI was not different.
In addition, serum AMH levels and pelvic ultrasound
were similar in both groups. We also performed an hor-
monal study in both groups of girls, but we did not ob-
serve any differences in the basal concentrations of
gonadotropins or sex steroid concentrations.
The investigation of the androgen receptor repeat
polymorphisms provided the most interesting results of
this study. Androgen receptor CAG repeats usually
range between 11 and 35, and a decreased CAG repeat
number has been linked to an increased transcriptional
response to androgens [25]. Van Nieuwerburgh et al.
studied 97 oligo-anovulatory women with ultrasound
features of PCOS, and observed that patients with a bi-
allelic mean lower than 21 repeats had lower androgen
levels, but more florid clinical evidence of acne and/or
hirsutism [26]. Ibañez et al. observed that girls with pre-
cocious pubarche had shorter mean CAG repeats and a
greater proportion of short alleles (20 repeats or less)
compared to controls. They concluded that shorter an-
drogen receptor CAG number is indicative of increasedGirls Total
Hypertrichosis Controls (n)
12 (28.6%) 4 (13.8%) 16
3 (7.1%) 0 (0%) 3
3 (7.1%) 6 (20.7%) 9
5 (11.9%) 6 (20.7%) 11
18 (42.9%) 13 (44.8%) 31
41 29 70
ore did not classify in any of this haplotypes.
girls with hypertrichosis than in controls (37.5% vs 13.8% P = 0.04 Chi2 test).
Table 4 Hormonal levels according to CAG/GGC haplotypes
Cases (n) Controls (n)
Hap 1-2 Hap 3-5 Hap 1-2 Hap 3-6
Age (years) 5.9 ± 2.2 (13) 59 ± 1.(23) 7.0 ± 1 8 (4) 6.0 ± 1.5 (25)
Hypertrichosis score 16.0 ± 3.3 (13)& 17.1 ± 3.2 (23)& 1.8 ± 1.0 (4) 3.5 ± 2.0 (25)
Follicle number per ovary 4.9 ± 1.5 (9) 5.0 ± 3.0 (17) 3.3 ± 1.0 (3) 3.8 ± 1.4 (15)
LH (mUI/mL) 0.5 ± 0.4 (11) 0.4 ± 0.1 (19)& 0.5 ± 0.1 (4) 0.5 ± 0.2 (22)
FSH 2,0 ± 1.0 (11) 2.0 ± 1.1 (19) 2.4 ± 0.8 (4) 2.9 ± 3.2 (22)
Testosterone (ng/mL) 0.1 ± 0.06 (11)* 0.2 ± 0.06 (23) 02 ± 0.08 (4) 0.1 ± 0.06 (23)
Androstenedione (ng/mL) 0.2 ± 0.6 (11)* 0.4 ± 0.49 (20) 0.2 ± 0.08 (4) 0.2 ± 0.16 (22)
DHEAS (ng/mL) 38 ± 39 (11)* 161 ± 190 (22) 81 ± 82 (4) 98 ± 86 (23)
17OH progesterone (ng/mL) 0.5 ± 0.2 (12) 0.7 ±0.4 (20) 04 ± 0.15 (4)* 0.8 ± 0.5 (22)
Estradiol 8.74 ± 6.5 (11) 749 ± 4.2 (19) 7.45 ± 3.7 (4) 8.38 ± 4.7 (22)
SHBG (nmoL/L) 77.2 ± 16.7 (12) 68.2 ± 15.6 (19)& 79.3 ± 18 (4) 82.4 ± 15 (22)
FAI 0.54 ± 0.36 (11) 0.98 ± 0.77 (22)& 0.64 ± 0.18 (41) 0.62 ± 0.39 (23)
AMH (pmol/L) 41.6 ± 24.7 (12)* 23.8 ± 17.9 (20) 30.1 ± 5.9 (4) 22.4 ± 10.2 (22)
Inhibin B (pg/mL) 18.9±18 (12)& 14 ± 11 (20) 8.3 ± 3.3 (4) 12 ± 4.1 (22)
Values are mean ± DS. *P<0.03 hap 1–2 versus hap 3–6 in cases or controls; &P<0.05 cases vs controls. Krustal Wallis Test.
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drogenism [27]. In addition, Vottero et al. reported a re-
duced androgen receptor gene methylation pattern,
which was associated with the presence of shorter CAG
repeats, in girls with precocious pubarche. This constel-
lation of findings might lead to hypersensitivity of the
hair follicles to androgens, and therefore to the prema-
ture development of pubic hair [28].
On the other hand, in vitro characterization has
showed a higher transactivating capacity for GGN 23 al-
lele (GGC 17), and GGN 27 or GGN 10, compared to
GGN 24 with a constant CAG repeat number of CAG
22, in response to testosterone analogs (R1881) and 5-α
dihydrotestosterone. In accordance with several reports,
our GGC distribution showed that GGC 17 and GGC 18
were the most frequent alleles in our population.
In the present study we did not find differences in the
mean number of CAG or GGC repeats. In order to in-
vestigate the combined contribution of the CAG and
GGC alleles to androgen sensitivity, we performed a
study of the joint distribution of these alleles. The com-
bined analysis of CAG/GGC showed a significantly
higher prevalence of the most androgen-sensitive combi-
nations (<18 CAG + 17/17 GGC and <14 CAG + 17/18
GGC) in the girls with hypertrychosis. The normal an-
drogen levels in haplotypes 1 and 2 indicates that they
may develop hypertrichosis due to enhanced androgen
receptor sensitivity. The higher AMH and inhibin B
levels observed in these patients, suggests that they ap-
pear to have a higher number of small antral follicles, as
observed in patients with PCO. In addition, the girls
who harbored combinations 3 – 5 had lower SHBGconcentrations compared to controls. This hormonal
pattern may lead to the development of hypertrichosis
due to a higher free androgen index. The lower LH
levels observed in these patients may be consequence of
the central negative feedback by androgens.
Although it is known that analyzing blood DNA may
not reflect target tissue AR sensitivity, we did not per-
form skin biopsies to study AR sensitivity due to ethical
considerations.
Conclusions
In conclusion, we have studied the hormonal profile and
androgen receptor polymorphisms in a group of pre-
pubertal girls with hypertrichosis. Girls with hypertri-
chosis exhibited lower levels of SHBG, but had
otherwise normal androgen levels. The association of
GGC 17 + CAG < 18 repeats suggests that some girls
with hypertrichosis may have androgen receptors with
enhanced sensitivity, which may facilitate the growth of
their body hair. In order to clarify the contribution of
each androgen receptor repeat, it will be important to
study the methylation of the androgen receptor in these
patients.
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